{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:30:50Z","timestamp":1793781050627,"version":"4.6.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T00:00:00Z","timestamp":1530230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["460453"],"award-info":[{"award-number":["460453"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.amjcard.2018.05.011","type":"journal-article","created":{"date-parts":[[2018,6,2]],"date-time":"2018-06-02T11:47:13Z","timestamp":1527940033000},"page":"762-767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Risk of Incident Atherosclerotic Cardiovascular DiseaseEvents by Achieved Atherogenic Lipid Levels Among62,428 Statin-Treated Individuals With Diabetes Mellitus"],"prefix":"10.1016","volume":"122","author":[{"given":"Jamal S.","family":"Rana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9702-7415","authenticated-orcid":false,"given":"Jennifer Y.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8728-774X","authenticated-orcid":false,"given":"Howard H.","family":"Moffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan H.","family":"Boklage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Karter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2018.05.011_bib0001","series-title":"National Diabetes Statistics Report A","year":"2017"},{"key":"10.1016\/j.amjcard.2018.05.011_bib0002","first-page":"2215\u22122222","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2018.05.011_bib0003","doi-asserted-by":"crossref","first-page":"2889\u22122934","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.05.011_bib0004","first-page":"343\u2212349","article-title":"An evidence-based guide to cholesterol-lowering guidelines","volume":"33","author":"Waters","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjcard.2018.05.011_bib0005","doi-asserted-by":"crossref","first-page":"485\u2212494","DOI":"10.1016\/j.jacc.2014.02.615","article-title":"Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials","volume":"64","author":"Boekholdt","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"10106","key":"10.1016\/j.amjcard.2018.05.011_bib0006","doi-asserted-by":"crossref","first-page":"1962\u22121971","DOI":"10.1016\/S0140-6736(17)32290-0","article-title":"Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial","volume":"390","author":"Giugliano","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2018.05.011_bib0007","doi-asserted-by":"crossref","first-page":"547\u2212555","DOI":"10.1001\/jamacardio.2017.0083","article-title":"Long-term safety and efficacy of achieving very low levels of low-density lipoprotein cholesterol: a prespecified analysis of the IMPROVE-IT trial","volume":"2","author":"Giugliano","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"14","key":"10.1016\/j.amjcard.2018.05.011_bib0008","first-page":"1785\u22121822","volume":"70","author":"Writing Committee","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.05.011_bib0009","doi-asserted-by":"crossref","first-page":"2519\u22122527","DOI":"10.1001\/jama.287.19.2519","article-title":"Ethnic disparities in diabetic complications in an insured population","volume":"287","author":"Karter","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2018.05.011_bib0010","doi-asserted-by":"crossref","first-page":"574\u2212579","DOI":"10.2337\/dc12-0722","article-title":"Elevated rates of diabetes in Pacific Islanders and Asian subgroups: The Diabetes Study of Northern California (DISTANCE)","volume":"36","author":"Karter","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2018.05.011_bib0011","doi-asserted-by":"crossref","first-page":"1301\u22121309","DOI":"10.2337\/dc11-2281","article-title":"Predictors of mortality over 8years in type 2 diabetic patients: Translating Research Into Action for Diabetes (TRIAD)","volume":"35","author":"McEwen","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2018.05.011_bib0012","doi-asserted-by":"crossref","first-page":"373\u2212383","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.amjcard.2018.05.011_bib0013","doi-asserted-by":"crossref","first-page":"685\u2212696","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2018.05.011_bib0014","first-page":"117\u2212125","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"Kearney","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2018.05.011_bib0015","doi-asserted-by":"crossref","first-page":"883\u2212893","DOI":"10.1016\/j.jacc.2017.07.001","article-title":"Primary prevention of cardiovascular disease in diabetes mellitus","volume":"70","author":"Newman","year":"2017","journal-title":"J Am Coll Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918311834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918311834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:04:08Z","timestamp":1762077848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914918311834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0002914918311834"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.05.011","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Incident Atherosclerotic Cardiovascular DiseaseEvents by Achieved Atherogenic Lipid Levels Among62,428 Statin-Treated Individuals With Diabetes Mellitus","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}